Latest News
WHO and ICC Recognize Primary CAD as a New Diagnostic Entity
Study Supports Approved Dosing Regimen for Sutimlimab in CAD
Researchers Develop Symptom and Impact Questionnaire for CAD
IgM MGUS Can Lead to Cold Agglutinin Disease, New Study Finds
Cold Agglutinin Disease Diagnosed During Cardiopulmonary Bypass
Effectiveness of C1-INH Treatment in Severe CM-AIHA Unclear
New Study Set to Collect Data on Patients With CAD and CAS
High Grades of DAT May Predict Severe Anemia in Patients with AIHA
Case Report: Autoimmune Hemolytic Anemia and Sarcoidosis
Case Report: 71-Year-Old Woman With Refractory Hemolytic Anemia
New Study Set to Assess Povetacicept in Adults With CAD and Other Cytopenias
AI-Driven Models May Be Useful in Detecting Cold Agglutinin Disease
Study Explores Cases of Babesiosis-Related Autoimmune Hemolytic Anemia
Cold Agglutinin Disease Could Be Misdiagnosed as Spurious Macrocytic Anemia
CAD Clinical Trials
CAD Insights
Understanding the Burden of Cold Agglutinin Disease
Patients who suffer from cold agglutinin disease describe struggles in coping with their condition, especially during cold seasons.
The Importance of Blood Transfusions in Treating Autoimmune Hemolytic Anemia
Blood transfusions need to be administered in a timely manner in patients with autoimmune hemolytic anemia.
A Case Study of Cold Agglutinin Disease in a Patient With Antiphospholipid Syndrome
Although rare, cold agglutinin disease has been known to occur in conjunction with antiphospholipid syndrome.
Managing CAD in Conjunction With Newly Diagnosed Renal Cancer
When a patient presents with multiple comorbidities, it is important to categorize them as being either acute or chronic. However, sometimes acute diseases exacerbate chronic ones and physicians have to make a difficult decision on the best treatment regimen for the patient. This is rarely straightforward and often requires multidisciplinary input. In some cases, the…
Patient Perspectives
Reflecting on Quality of Life With CAD
Cold agglutinin disease (CAD) is a rare form of autoimmune hemolytic anemia and little is known about the impact of the disease.
A CAD Patient’s Take on the Future of Telehealth
Living with cold agglutinin disease (CAD) means a lot of doctor appointments.
Reading the Signs: CAD and Tinnitus
Cold agglutinin disease (CAD) comes with some of the weirdest symptoms—some I didn’t even know about until recently.
CAD Features
At 40, Orphan Drug Act Enjoys Rare Bipartisan Support
Rare disease advocates are marking the 40th anniversary of the landmark Orphan Drug Act, which has led to over 1100 approvals for new therapies.
Florida Fiber Artist Advocates for Fellow Cold Agglutinin Disease Patients
Abstract artist Betty Usdan-Zwickler, 83, of Boca Raton, Florida, is also a fierce advocate for fellow patients with cold agglutinin disease (CAD).
CAD Foundation Strives to Increase Knowledge of Rare Autoimmune Hemolytic Anemia
The all-volunteer CAD Foundation fights for patients with a rare anemia that has no approved therapy. Three companies are conducting clinical trials.
Updates on the Treatment of Cold Agglutinin Disease
Given the rarity of CAD and lack of comparative trials, treatment plans are primarily based on findings from nonrandomized trials and clinical experience.
Rare Care Podcast
- Loading...
Loading...
Loading... 
Loading...